The SURMOUNT-1 trial found that people using Mounjaro (tirzepatide) maintained an average weight loss of 19.4 percent over three years
GLP-1s dont fix that, but they support it
In cardiovascular outcome trials (CVOTs) such as Empagliflozin Cardiovascular Outcome Event Trial in Type 2 diabetes Mellitus Patients (EMPA-REG OUTCOME), CANagliflozin cardioVascular Assessment Study (CANVAS) and The Dapagliflozin Effect on Cardiovascular EventsThrombolysis in Myocardial Infarction 58 (DECLARE-TIMI 58) [6], they reduced the onset and progression of DKD, which was confirmed in the dedicated kidney trial The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE), which showed a canagliflozin-induced risk reduction for ESKD in people with DKD by 32% [7]
Im in Scotland, and had to pay out of pocket, but it was worth every penny
This does not affect the quality or benefits of the product
With Jennifer, Daniell feels comfortable discussing her health journey and overall wellness over the past few years without judgment